Date	Event	Description
10 September 2020	New citation required but conclusions have not changed	The title of this review has been changed to reflect the inclusion of all drug treatments for managing cystic fibrosis‐related diabetes. Despite the identification of new references, no data have been added to the review and our conclusions remain the same.
10 September 2020	New search has been performed	A search of the Cochrane Cystic Fibrosis and Genetic Disorders Review Group's Cystic Fibrosis Trials Register and additional online searching identified 12 new references which were potentially eligible for inclusion in the review. One reference was an additional reference (full paper) to an already included study (Ballmann 2018b). Six were references to newly excluded studies (Eiel 2018; Geyer 2019; NCT01149005; NCT02496780; Sc 2010) and three were additional references to two already excluded studies (Beaudoin 2015; Minicucci 2012). Two trials each with a single reference are currently listed as ongoing (NCT01851694; NCT02202876). Summary of findings tables have been added for each comparison presented in this review.